FDA Inspection 672893 — Centrient Pharmaceuticals Spain S.A.
The FDA completed an inspection of Centrient Pharmaceuticals Spain S.A. on July 15, 2010 in Santa Perpetua De Mogoda. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 15, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Santa Perpetua De Mogoda (Spain)